Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-08 · accession 0001209191-24-003008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-08 | 2024-02-08 | VKTX | Rouan Sarah Kathryn | Dir | M - OptEx | $8.32 | +25.0K | 25.0K | New | +$208.0K |
| D | 2024-02-08 | 2024-02-08 | VKTX | Rouan Sarah Kathryn | Dir | S - Sale+OE | $28.05 | -25.0K | 0 | -100% | -$701.2K |
| D | 2024-02-08 | 2024-02-08 | VKTX | Rouan Sarah Kathryn | Dir | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | M | A | 25,000 | $8.32 | 25,000 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | S | D | 25,000 | $28.05 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-02-08 | M | D | 25,000 | $0.00 | 0 | D | $8.32 · 2020-07-01 to 2029-07-01 | 25,000 Common Stock |